Ro 31-0313
Code | Size | Price |
---|
TAR-T34357-100mg | 100mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T34357-500mg | 500mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20°C
Images
Documents
Further Information
Bioactivity:
Ro 31-0313 is a metabolite of Ro 03-8799, radiation sensitizing agent.
CAS:
77273-77-9
Formula:
C11H18N4O4
Molecular Weight:
270.289
Purity:
0.98
SMILES:
OC(Cn1ccnc1N(=O)=O)CN1(=O)CCCCC1
References
Walton MI, Bleehen NM, Workman P. Effects of localised tumour hyperthermia on pimonidazole (Ro 03-8799) pharmacokinetics in mice. Br J Cancer. 1989 May;59(5):667-73. PubMed PMID: 2736198; PubMed Central PMCID: PMC2247237.
Walton MI, Bleehen NM, Workman P. The effects of whole body hyperthermia on the pharmacokinetics and toxicity of the basic 2-nitroimidazole radiosensitizer Ro 03-8799 in mice. Br J Cancer. 1987 May;55(5):469-76. PubMed PMID: 3606940; PubMed Central PMCID: PMC2001726.
Malcolm SL, Lee A, Groves JK. High-performance liquid chromatographic analysis of the new hypoxic cell radiosensitiser, Ro 03-8799, in biological samples. J Chromatogr. 1983 Apr 8;273(2):327-33. PubMed PMID: 6863447.